Everence Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $276K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $202 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $203 | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $238K | Hold |
|
|||||
|
2022
Q2 | $246K | Hold |
|
|||||
|
2022
Q1 | $310K | Hold |
|
|||||
|
2021
Q4 | $426K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $469K | Hold |
|
|||||
|
2018
Q2 | $354K | Buy |
|
|||||
|
2018
Q1 | $210K | Buy |
|